Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults
Clinical trial NCT00368251 · COMPLETED
Trial details
- NCT number
- NCT00368251
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-01-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.